Animal diseases

The Only Proven, Effective Bovine Anaplasmosis Vaccine Available for a Global Cattle Market: 'University Products LLC' Highlights Two Decades of Success with Proprietary Formula - Also Offers Hope in Global Fight Against Bovine Babesiosis

Retrieved on: 
Wednesday, April 14, 2021
Tick-borne diseases, Rickettsioses, Anaplasmosis, Animal diseases, Infection

Although it does not prevent infection, it significantly reduces clinical signs and helps prevent cattle death.

Key Points: 
  • Although it does not prevent infection, it significantly reduces clinical signs and helps prevent cattle death.
  • News of our vaccine has quietly circulated via word-of-mouth and through internal press releases.
  • This is a cost-effective answer to the U.S. anaplasmosis problem, and we know our product works.
  • "\nFor more information on the ongoing study, or to read Dr. Thompson\'s full analysis of anaplasmosis treatment, contact Dr. Luther directly by email at [email protected] .\n'

NuWave Voluntarily Modifies Certain OxyPure Air Purifier Claims Following National Advertising Division Inquiry into Implied COVID-19 Messages

Retrieved on: 
Tuesday, April 13, 2021
Sarbecovirus, Zoonoses, Animal diseases, Medical specialties, Children's Advertising Review Unit, NuWave, Severe acute respiratory syndrome, Coronavir

Sleeping problems are epidemic and carry their own health risks.

Key Points: 
  • Sleeping problems are epidemic and carry their own health risks.
  • However, it agreed to modify its website advertising to state: "OxyPure is Calculated to Remove 99.999% of Coronavirus Surrogate from the Air in Areas up to 1,200 Square Feet in 6 Hours!
  • * which is qualified by a clear and conspicuous disclosure directly underneath the claim, stating that "SARS-COV-2 was not used in the study conducted by the University of Minnesota for the efficacy of NuWave OxyPure.
  • For full text of NAD, NARB, and CARU decisions, subscribe to the online archive .\nAbout BBB National Programs:BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard.

USAID launches Cargill, Ausvet, Heifer International and IPC consortium to combat threat of infectious diseases, antimicrobial resistance to human and animal health

Retrieved on: 
Monday, April 12, 2021
Meat industry, Animal diseases, Zoonosis, Livestock

b'WASHINGTON, April 12, 2021 /PRNewswire/ --The United States Agency for International Development (USAID) has tapped a consortium led by Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC) to improve livestock management and combat the threat of zoonotic diseases to both human and animal health.

Key Points: 
  • b'WASHINGTON, April 12, 2021 /PRNewswire/ --The United States Agency for International Development (USAID) has tapped a consortium led by Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC) to improve livestock management and combat the threat of zoonotic diseases to both human and animal health.
  • The group will also consider transboundary animal diseasesiii(TADs,) such as foot-and-mouth disease and African swine fever.
  • We have a multidisciplinary team working across human, terrestrial and aquatic animal, and plant health, using a One Health approach recognizing the complex connections within the ecosystem.
  • For information, visit https://www.heifer.org .\nThe International Poultry Council (IPC) is the voice of the global poultry meat industry.

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2021 Quarterly Financial Results

Retrieved on: 
Thursday, April 8, 2021
Health, Other Natural Resources, Consumer, Agriculture, Natural Resources, Pets, Veterinary, Animal diseases, Phibro, Veterinarian, Veterinary medicine

Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Thursday, May 6, 2021, after the market closes.

Key Points: 
  • Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Thursday, May 6, 2021, after the market closes.
  • Phibro management will host a conference call and webcast on Friday, May 7, 2021 at 9:00 AM Eastern Time.
  • Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com .
  • Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.

NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications

Retrieved on: 
Wednesday, March 31, 2021
Science, Biotechnology, Research, Health, Data management, Infectious diseases, Technology, Genetics, Sarbecovirus, Respiratory diseases, Zoonoses, Animal diseases, Bat virome, Data mining, Identity management, Profiling, COVID-19, Profiler, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx Digital Spatial Profiler have been published in Nature and Nature Communications.

Key Points: 
  • NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx Digital Spatial Profiler have been published in Nature and Nature Communications.
  • These papers describe the use of Digital Spatial Profiling (DSP) technology to investigate SARS-CoV-2 infection and drive diagnostic, prevention, and treatment strategies.
  • The GeoMx DSP was used to profile lung tissue collected on autopsy from patients who had succumbed to COVID-19 infection.
  • The companys GeoMx Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.

Global Acute Vulvovaginal Candidiasis Treatment Market to Surpass US$ 397.8 Million by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Monday, March 29, 2021
General Health, Pharmaceutical, Health, Animal diseases, Candidiasis, Vaginal yeast infection

According to Coherent Market Insights, the global acute vulvovaginal candidiasis treatment market is estimated to be valued at US$ 308.0 million in 2020 and is expected to exhibit a CAGR of 3.0% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global acute vulvovaginal candidiasis treatment market is estimated to be valued at US$ 308.0 million in 2020 and is expected to exhibit a CAGR of 3.0% during the forecast period (2020-2027).
  • Market players are involved in publishing positive clinical trial results for the treatment of vulvovaginal candidiasis in the peer-reviewed journal, which is expected to drive growth of the acute vulvovaginal candidiasis treatment market over the forecast period.
  • Increasing research and development activities for developing new treatment for vulvovaginal candidiasis is expected to drive the global acute vulvovaginal candidiasis treatment market growth over the forecast period.
  • Among regions, North America is expected to hold a dominant position in the global acute vulvovaginal candidiasis treatment market over the forecast period, owing to increasing prevalence of acute vulvovaginal candidiasis treatment in this region.

AcademicInfluence.com Welcomes Editor Dave Tomar, Expert on Cheating, As He Addresses COVID-19's Impact on the Student Cheating Surge

Retrieved on: 
Monday, March 29, 2021
Sarbecovirus, Zoonoses, Articles, Animal diseases, Bat virome, Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus, Pandemic, Severe acute respiratory syndrome, Ed Dante, Middle East respiratory syndrome–related coronavirus, Coronavir

Sadly, cheating is rampant at all levels of education, and it may have an ally in an unlikely source: SARS-CoV-2, the novel coronavirus.

Key Points: 
  • Sadly, cheating is rampant at all levels of education, and it may have an ally in an unlikely source: SARS-CoV-2, the novel coronavirus.
  • Today, AcademicInfluence.com tackles this challenge of pandemics and cheating with its own triple threat, naming Dave Tomar its new Managing Editor.
  • The article explores student despair as a core driver of cheating at a time when students have never been more vulnerable or at risk.
  • AcademicInfluence.com is a part of the EducationAccess group, a family of sites dedicated to lifelong learning and personal growth.

Therma Bright Partners with Ridge Global to Expand Its United States and Global Reach

Retrieved on: 
Wednesday, March 24, 2021
Bat virome, Sarbecovirus, Severe acute respiratory syndrome, Therma, COVID-19, Health, Animal diseases, Medical specialties

The agreement focuses on supporting the Company's reach across the United States and Global marketplace business community along with extending policy advisory services in the U.S.

Key Points: 
  • The agreement focuses on supporting the Company's reach across the United States and Global marketplace business community along with extending policy advisory services in the U.S.
    "We're excited to add Ridge Global to our growing advisory team," expressed Rob Fia, CEO of Therma Bright.
  • "Governor Ridge will serve as a Senior Advisor and support his team in corporate strategy and business development on behalf of Therma Bright."
  • Therma Bright is not making any express or implied claims that its test product has the ability to eliminate or cure COVID-19 or the SARS-CoV-2 virus.
  • Therma Bright is a progressive medical device technology company focused on providing consumers and medical professionals with quality medical devices that address their medical and healthcare needs.

Carolina Liquid Chemistries Corp. Continues to Add to its Point-of-Care Product Offering with the FDA Emergency Use Authorized Status™ COVID-19/Flu A&B Combo Test

Retrieved on: 
Tuesday, March 23, 2021
Respiratory diseases, COVID-19, Occupational safety and health, Public health, Zoonoses, Severe acute respiratory syndrome, Health, Animal diseases

GREENSBORO, N.C., March 23, 2021 /PRNewswire/ --Carolina Liquid Chemistries Corp. announces the most recent addition to their Point-of-Care product line.

Key Points: 
  • GREENSBORO, N.C., March 23, 2021 /PRNewswire/ --Carolina Liquid Chemistries Corp. announces the most recent addition to their Point-of-Care product line.
  • Carolina Liquid Chemistries Corp. now has the Emergency Use Authorized Status COVID-19/Flu A&B Combo Test from LifeSign, a Princeton BioMeditech Group Company.
  • It is intended to aid in the rapid differential diagnosis of SARS-CoV-2, Influenza A, and B viral infections.
  • The Status COVID-19/Flu A&B Combo Test is a vital combination test for the current market.

IDbyDNA Boosts Its Global Metagenomic Respiratory Pathogen/AMR Surveillance Solution to Now Offer Enhanced SARS-CoV-2 Variant Interpretation

Retrieved on: 
Tuesday, March 23, 2021
Sarbecovirus, Zoonoses, Branches of biology, Animal diseases, Articles, Severe acute respiratory syndrome coronavirus, Polymerase chain reaction, COVID-19, Severe acute respiratory syndrome, Human coronavirus HKU1

The widely used PCR and rapid antigen tests cannot detect these variants, allowing the virus to evolve in stealth mode.

Key Points: 
  • The widely used PCR and rapid antigen tests cannot detect these variants, allowing the virus to evolve in stealth mode.
  • Early identification and monitoring of SARS-CoV-2 will help public health officials and researchers better understand the evolving virus.
  • Today, IDbyDNA is announcing significant enhancements to its fully automated data analysis suite for the combined IDbyDNA and Illumina, Inc. Respiratory Pathogen ID/AMR Target Enrichment Panel (RPIP).
  • "The key to managing COVID-19, influenza, and other emerging respiratory infections, is more robust and real-time genomic-level insights into circulating strains.